Clinicopathologic Characteristics and Prognostic Features of Well-Differentiated Pancreatic Neuroendocrine Tumors in MEN1 Syndrome: A Cohort Study of 39 MEN1 Patients and 778 Non-MEN1 Patients with 7752 Person-Year Follow-Up
Endocrines · 2026-11-06 · 7 (4) · 70
DOI: 10.3390/endocrines7040070 ↗Abstract
Background: Well-differentiated pancreatic neuroendocrine tumors (PanNETs) develop in ~80% of patients with multiple endocrine neoplasia type 1 (MEN1) and remain the leading cause of MEN1-related mortality. Whether MEN1-associated PanNETs display distinct clinicopathologic or prognostic characteristics compared with non-MEN1 PanNETs remains incompletely defined. Methods: We retrospectively reviewed clinical, pathological, and outcome data from 817 patients who underwent surgical resection for well-differentiated PanNETs, including 39 MEN1-associated and 778 non-MEN1 PanNETs, with a total of 7752 person-years of follow-up. Tumor characteristics, stage, and survival outcomes were compared between two groups. Results: MEN1-associated PanNETs represented 4.8% of the cohort and included both functional and non-functional tumors. Patients with MEN1 more frequently had functional tumors, with insulinomas and gastrinomas predominating. Patients with MEN1 were significantly younger at surgery. Tumor size and grade distribution were similar between the two groups, although tumors >2 cm were more prevalent in patients with MEN1. MEN1-associated tumors demonstrated significantly lower rates of lymphovascular and perineural invasion, but similar rates of lymph node metastasis and stage III disease when only lymph node metastases attributable to a pancreatic primary were included. Long-term overall survival, disease-specific survival, and cumulative incidence of relapses did not differ significantly between MEN1 and non-MEN1 patients. Conclusions: In this retrospective cohort of surgically resected, well-differentiated PanNETs, MEN1-associated tumors exhibited similar histologic grade and tumor size distributions to non-MEN1 PanNETs. MEN1 status was associated with a higher prevalence of functional tumors and lymph node metastases, but lower rates of vascular and perineural invasion. Despite these features, no statistically significant differences in long-term overall survival, disease-specific survival, or cumulative incidence of relapse were observed between surgically resected patients with and without MEN1, though the study was underpowered to detect modest differences.
EUVIMED